Overview

A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin)

Status:
COMPLETED
Trial end date:
2025-08-19
Target enrollment:
Participant gender:
Summary
This trial is a single-center, open-label, fixed-sequence, self-controlled clinical study to evaluate Drug-Drug Interaction Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets (Yasmin)
Phase:
PHASE1
Details
Lead Sponsor:
Hansoh BioMedical R&D Company
Treatments:
drospirenone
Ethinyl Estradiol